Efthimios Deligeoroglou

Prof. Dr. Efthimios Deligeoroglou

2nd Department of Obstetrics & Gynecology, Medical School, National and Kapodistrian University of Athens, 11 528 Athens, Greece

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2010 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Efthimios DeligeoroglouEfthimios Deligeoroglou
Efthimios Deligeoroglou
NANikolaos Athanasopoulos
Nikolaos Athanasopoulos
PTPandelis Tsimaris
Pandelis Tsimaris
KDKonstantinos D. Dimopoulos
Konstantinos D. Dimopoulos
NVNikolaos Vrachnis
Nikolaos Vrachnis
GCG. Creatsas
G. Creatsas

20 December 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KSKonstantinos Sfakianoudis
Konstantinos Sfakianoudis
Mara SimopoulouMara Simopoulou
Mara Simopoulou
NNNikolaos Nitsos
Nikolaos Nitsos
ARAnna Rapani
Anna Rapani
APAthanasios Pappas
Athanasios Pappas
KPKonstantinos Pantos
Konstantinos Pantos
This report presents the case of a woman aged 40 who has experienced premature menopause from the age of 35. Having rejected oocyte donation, she opted for intraovarian injection of autologous platelet-rich plasma with the aim to rejuvenate the ovarian tissue and enable the employment of her own gametes through in-vitro fertilization. Six weeks following the autologous platelet-rich plasma treatment, a significant reduction in the patient’s follicle-stimulating hormone (FSH) levels were noted. A natural in-vitro fertilization cycle led to a biochemical pregnancy, resulting in a spontaneous abortion at the 5th week of pregnancy. This is the first report of a successful autologous platelet-rich plasma application leading to pregnancy in menopause. This report uniquely contributes to the medical knowledge and challenges current practice in the context of infertility. The efficiency and safety of this treatment with regard to the reproductive system merits further investigation.

20 July 2012 in Gynecological Endocrinology
Verified
Journal Article
Closed access
PDF file
Efthimios DeligeoroglouEfthimios Deligeoroglou
Efthimios Deligeoroglou
VKVasileios Karountzos
Vasileios Karountzos
GCGeorge Creatsas
George Creatsas
Abnormal uterine bleeding (AUB), which is defined as excessively heavy, prolonged and/or frequent bleeding of uterine origin, is a frequent cause of visits to the Emergency Department and/or health care provider. While there are many etiologies of AUB, the one most likely among otherwise healthy adolescents is dysfunctional uterine bleeding (DUB), which is characterizing any AUB when all possible underlying pathologic causes have been previously excluded. The most common cause of DUB in adolescence is anovulation, which is very frequent in the first 2–3 post-menarchal years and is associated with immaturity of the hypothalamic – pituitary – ovarian axis. Management of AUB is based on the underlying etiology and the severity of the bleeding and primary goals are prevention of complications, such as anemia and reestablishment of regular cyclical bleeding, while the management of DUB can in part be directed by the amount of flow, the degree of associated anemia, as well as patient and family comfort with different treatment modalities. Treatment options for DUB are: combined oral contraceptives (COCs), progestogens, non steroidal anti inflammatory drugs (NSAIDs), tranexamic acid (anti-fibrinolytic), GnRH analogues, Danazol and Levonorgestrel releasing intra uterine system (LNG IUS).

1 April 2018 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
Efthimios DeligeoroglouEfthimios Deligeoroglou
Efthimios Deligeoroglou
VKVasileios Karountzos
Vasileios Karountzos

25 October 2018 in Medicina
Verified
Journal Article
Open access
PDF file
Mara SimopoulouMara Simopoulou
Mara Simopoulou
KSKonstantinos Sfakianoudis
Konstantinos Sfakianoudis
PBPanagiotis Bakas
Panagiotis Bakas
Polina GiannelouPolina Giannelou
Polina Giannelou
CPChristina Papapetrou
Christina Papapetrou
Michael KoutsilierisMichael Koutsilieris
Michael Koutsilieris
Oocyte freezing for ‘social reasons’ refers to women of reproductive age who are aiming to prolong, protect and secure their fertility. The term emerged to describe application of the highly promising technique, namely vitrification on oocytes retrieved through controlled ovarian stimulation (COS) from women intending to preserve their fertility for social reasons. These women opt to cryopreserve their oocytes at a point in their life when they need to postpone childbearing on the grounds of so called ‘social’ reasons. These reasons may include a highly driven career, absence of an adequate partner, financial instability, or personal reasons that make them feel unprepared for motherhood. This is a sensitive and multifaceted issue that entails medical, bioethical and socio-psychological components. The latest trend and the apparent increase noted on oocyte freezing for ‘social reasons’ has prompted our team of fertility specialists, embryologists, obstetricians, gynecologists and psychologists to proceed with a thorough, critical and all-inclusive comprehensive analysis. The wide range of findings of this analysis involve concerns of embryology and epigenetics that shape decisions made in the IVF laboratory, issues regarding obstetric and perinatal concerns on the pregnancy concluding from these oocytes and the respective delivery management and neonatal data, to the social and bioethical impact of this trend’s application. This literature review refers to matters rising from the moment the ‘idea’ of this option is ‘birthed’ in a woman’s thoughts, to proceeding and executing it clinically, up until the point of the pediatric follow up of the children born. We aim to shed light to the controversial issue of oocyte freezing, while objectively exhibit all aspects regarding this complex matter, as well as to respectfully approach how could the prospect of our future expectations be shaped from the impact of its application.

30 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Andreas ZouridisAndreas Zouridis
Andreas Zouridis
AMAntigoni Manousopoulou
Antigoni Manousopoulou
Anastasios PotirisAnastasios Potiris
Anastasios Potiris
PSPolyxeni-Maria Sarli
Polyxeni-Maria Sarli
LALeon Aravantinos
Leon Aravantinos
Makarios EleftheriadesMakarios Eleftheriades
Makarios Eleftheriades
Objective: Fetal growth restriction is associated with increased postnatal cardiovascular morbidity. The alterations in heart physiology and structure caused by in utero nutrient deprivation have not been extensively studied. We aim to investigate the impact of maternal food restriction on the cardiac proteome of newborn rats with normal (non-fetal growth-restricted (FGR)) and reduced (FGR) birth weight. Methods: On day 14 of gestation, 10 timed pregnant rats were randomized into two nutritional groups: (a) Standard laboratory diet and (b) 50% global food restriction. Pups born to food-restricted mothers were subdivided, based on birthweight, into fetal growth-restricted (FGR) and non-FGR, while pups born from normally nourished mothers were considered controls. Rat neonates were euthanized immediately after birth and the hearts of 11 randomly selected male offspring (n = 4 FGR, n = 4 non-FGR, n = 3 control group) were analyzed using quantitative proteomics. Results: In total, 7422 proteins were quantified (q < 0.05). Of these, 1175 were differentially expressed in FGR and 231 in non-FGR offspring vs. control with 151 common differentially expressed proteins (DEPs) between the two groups. Bioinformatics analysis of DEPs in FGR vs. control showed decreased integrin and apelin cardiac fibroblast signaling, decreased muscle contraction and glycolysis, and over-representation of a protein network related to embryonic development, and cell death and survival. Conclusion: Our study illustrates the distinct proteomic profile of FGR and non-FGR offspring of food-restricted dams underlying the importance of both prenatal adversities and birth weight in cardiac physiology and development.